Wednesday, October 14, 2026, 12pm-1pm

From Idea to Impact: How Clinical Research Gets Done at Stanford Medicine Children's Health

By the end of this webinar, participants will be able to:

• Understand who we are: Learn about the Clinical Research Support Office and our role within Stanford Medicine Children’s Health.

• Know how we can help: Understand how our team can support investigators throughout the clinical research process.

• Explore our services: Become familiar with the clinical research resources, services, and expertise available through our office.

• Connect to Stanford Medicine: Learn about the Stanford Medicine research activities, programs, and initiatives in which our office is engaged.

Presenters:

Karl G. Sylvester, MD

Alyson Falwell, MPH

Kevin Morrison, MS

Ana Coggin, MS

Sijo Thomas, RN, MSN, MBA

Monday, November 9, 2026, 12pm-1pm

Development of Non-Genotoxic Cell and Gene Therapies Through the Lens of Fanconi Anemia

This talk will look at how hematopoietic stem cell transplantation (HSCT) can be made safer by moving away from toxic chemotherapy and radiation. Fanconi Anemia (FA) is an inherited DNA repair disorder whose patients are especially vulnerable to DNA-damaging (genotoxic) treatments, which makes it a useful model for this work. We will cover what HSCT can and cannot do today and where antibody-based conditioning stands as a targeted, non-genotoxic alternative. We will also show how these advances, together with ex vivo gene therapy and prenatal stem cell transplantation, are changing treatment options for children with FA and other inherited blood and immune disorders. Finally, we will highlight the path from lab discovery to first-in-human clinical trials and what it means for maternal and children's health.

Learning Objectives

Participants will gain insight into:

1. Opportunities and limitations of hematopoietic stem cell transplantation.
2. Antibody-based conditioning and the current state of the field.
3. Innovation in treatments for Fanconi Anemia (FA): improved stem cell transplantation with antibody-based conditioning, ex vivo lentiviral gene therapy, and prenatal stem cell transplantation.

Presenter(s):

• Agnieszka Czechowicz, MD, PhD, Assistant Professor of Pediatrics (Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine), Stanford University School of Medicine

Wednesday, September 30,  2026, 1pm – 2pm 

Using Epic to Support Clinical Research: Current Capabilities, Practical Workflows, and What’s Ahead

Hosted by: Sijo Thomas and Kevin Morrison, Clinical Research Support Office, SMCH

By the end of this webinar, participants will be able to:

1. Understand how Epic can support clinical research across the study lifecycle, including research participant identification, documentation, coordination, and operational workflows.

2. Recognize the Epic research-related features currently enabled within Stanford Medicine Children’s Health and the research features that will be rolled out in the future. 

Monday, September 14, 2026, 12pm-1pm

Using Systems Thinking to Support Community Collective Action in Health Care

Complex social challenges such as housing insecurity, substance use, and adverse childhood experiences play a significant role in health outcomes and are especially impactful for historically marginalized and vulnerable populations. Addressing these issues often requires collaboration beyond traditional health care settings, including community-based solutions and policy-level change. This session will explore how health systems can leverage Systems Thinking to better understand complex challenges and strengthen partnerships with community stakeholders. Participants will learn how Systems Thinking approaches can support collective community action and help drive more effective, sustainable solutions in health care delivery.

Presenter:

Jason Cunningham